HomeInsightsPE

Concord Biotech Ltd PE Ratio

Concord Biotech Ltd PE Ratio

stocks purchased

₹ 0.1 Cr

Volume Transacted

(Dec 13, 2024)

stocks purchased

0.6 K

Stocks Traded

(Dec 13, 2024)

Last Updated on: Dec 13, 2024

Image

Concord Biotech Ltd

NSE: CONCORDBIO

PE

68.1

Last updated on: Dec 13, 2024

Key Highlights

  • The P/E Ratio of Concord Biotech Ltd is 68.1 as of 13 Dec 09:53 AM .
  • The P/E Ratio of Concord Biotech Ltd changed from 51.7 on March 2024 to 51.7 on March 2024 . This represents a CAGR of 0.00% over 1 years.
  • The Latest Trading Price of Concord Biotech Ltd is ₹ 2133 as of 13 Dec 09:46 .
  • The PE Ratio of Pharmaceuticals Industry has changed from 28.2 to 27.1 in 5 years. This represents a CAGR of -0.79%.
  • The PE Ratio of Automobile industry is 20.3. The PE Ratio of Finance industry is 17.8. The PE Ratio of IT - Software industry is 30.4. The PE Ratio of Pharmaceuticals industry is 40.0. The PE Ratio of Retail industry is 157.6. The PE Ratio of Textiles industry is 37.6 in 2024.

Historical P/E Ratio of Concord Biotech Ltd

No data available

Company Fundamentals for Concord Biotech Ltd

No data available

Image

Concord Biotech Ltd

NSE: CONCORDBIO

Share Price

₹ 2133.45

-2.80 (-0.13%)

stock direction

Last updated on: Dec 13, 2024

Market Price of Concord Biotech Ltd

1M

1Y

3Y

5Y

Monitoring Concord Biotech Ltd share price can help you stay informed about potential market shifts and opportunities. *All values are in Rupees.

Last Ten Days Market Price

Date
leftPrice (₹)right
12 Dec 20242136.25
11 Dec 20242197.55
10 Dec 20242093.65
09 Dec 20242097.3
06 Dec 20242170.75
05 Dec 20242199.35
04 Dec 20242179.2
03 Dec 20242194.55
02 Dec 20242188.55
29 Nov 20242124.45

SWOT Analysis Of Concord Biotech Ltd

Strength

2

S

Weakness

2

W

Opportunity

0

O

Threats

1

T

BlinkX Score for Concord Biotech Ltd

Revenue

Profitability

Affordability

Liquidity

Dividend

Asset Value vs Market Value of Concord Biotech Ltd

Market Value

0

Asset Value

0

* All values are in Rupees

Competitive Comparison of P/E Ratio

Company NamePEMarket Cap (INR Cr.)
Concord Biotech Ltd6822,348
Sun Pharmaceuticals Industries Ltd384,32,948
Divis Laboratories Ltd861,57,873
Cipla Ltd251,16,809
Torrent Pharmaceuticals Ltd641,12,638
Mankind Pharma Ltd501,06,198

Key Valuation Metric of Concord Biotech Ltd

No data available

No data available

PE Ratio of Pharmaceuticals Industry over time

PE Ratio of Top Sectors

Historical Market Cap of Concord Biotech Ltd

No data available

* All values are in crore

Historical Revenue of Concord Biotech Ltd

No data available

* All values are in crore

Historical EBITDA of Concord Biotech Ltd

No data available

* All values are in crore

Historical Net Profit of Concord Biotech Ltd

No data available

* All values are in crore

Historical Dividend Payout of Concord Biotech Ltd

No data available

* All values are in %

About Concord Biotech Ltd

  • Concord Biotech Ltd was originally incorporated as Servomed Pharmaceuticals Private Limited' at Ahmedabad, Gujarat as a Private Limited Company dated November 23, 1984, issued by the Registrar of Companies.
  • Thereafter, name of the Company was changed to Concord Biotech Limited' dated February 16, 2001, which became a Public Company and a fresh Certificate of Incorporation dated November 7, 2001 was issued by the RoC. The Company is an India-based biopharma and one of the leading global developers and manufacturers of select fermentation-based APIs across immuno-suppressants and oncology in terms of market share, based on volume in supplying to over 70 countries including regulated markets, such as the United States, Europe and Japan, and India.
  • Presently, it is engaged in research and development, manufacturing, marketing and selling of pharmaceutical products.

Concord Biotech Ltd News Hub

News

Concord Biotech consolidated net profit rises 9.36% in the June 2024 quarter

Net profit of Concord Biotech rose 9.36% to Rs 59.59 crore in the quarter ended June 2024 ...

Read more

2024-08-09 00:00:00

News

Volumes jump at Concord Biotech Ltd counter

K E C International Ltd, Sonata Software Ltd, TV18 Broadcast Ltd, ZF Commercial Vehicle Co...

Read more

2024-08-29 00:00:00

News

Concord Biotech to conduct board meeting

Concord Biotech will hold a meeting of the Board of Directors of the Company on 11 Novembe...

Read more

2024-11-06 00:00:00

News

Concord Biotech consolidated net profit rises 18.17% in the September 2024 quarter

Net profit of Concord Biotech rose 18.17% to Rs 95.74 crore in the quarter ended September...

Read more

2024-11-11 00:00:00

Product Composition

Document

Annual Reports

N/A

dropdown
download

Credit Ratings

N/A

dropdown
download

Concalls

Data not available

FAQs for PE of Concord Biotech Ltd

What is the current PE Ratio of Concord Biotech Ltd?

The Current PE Ratio of Concord Biotech Ltd is 68.14 as on 13 Dec 2024.

What is the average PE Ratio of the Pharmaceuticals industry?

The average industry PE Ratio of Pharmaceuticals is 40.0 as on 13 Dec 2024.

What was the PE Ratio of Concord Biotech Ltd last year?

The PE Ratio of Concord Biotech Ltd was 0.0 last year, now the PE ratio is 68.14, showing a year-on-year growth of -%.

What does the PE Ratio of Concord Biotech Ltd indicate about its stock?

The PE Ratio of Concord Biotech Ltd is 68.14. This ratio indicates that investors are willing to pay 68.14 times the earnings per share for each share of Concord Biotech Ltd.

What is the PE Ratio Growth of Concord Biotech Ltd in comparison to its Earnings per Share (EPS) growth rate?

The PE Ratio of Concord Biotech Ltd grew by -% whereas, the EPS ratio grew by 60.5.
Disclaimer: This information provided above is for informational purposes only and does not constitute investment advice. We use third-party data and recommend conducting thorough research and consulting a certified financial advisor before making investment decisions. We do not endorse specific stocks. Make decisions based on your own research and professional guidance.
up arrow
Open Demat Account
Verify your phone
+91
*By signing up you agree to our terms & conditions